MDI Therapeutics is a operator of an discovery stage company focused on developing novel therapies for fibrotic diseases.
MDI Therapeutics has raised $9.0M in total funding. The most recent round was Series A. The last funding was announced in March 2022.
MDI Therapeutics's investors include Juvenescence.
MDI Therapeutics is headquartered in Novi, United States.
MDI Therapeutics is a operator of an discovery stage company focused on developing novel therapies for fibrotic diseases.
MDI Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MDI Therapeutics — Funding & Investors." VCBacked, March 2, 2022, https://www.vcbacked.co/company/mdi-therapeutics. Accessed August 14, 2026.
VCBacked. (2022). MDI Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/mdi-therapeutics
{{cite web |title=MDI Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mdi-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated